HMOX1 and Alzheimer disease: Importantly, the percentage of double GFAP and HO-1-positive astrocytes is much higher in temporal cortex and hippocampus of MCI and AD patients compared to controls and shows a negative correlation with global cognitive performance and a positive one with AD pathology, with the latter apparent only in the temporal cortex [144].